Semaglutide

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that has garnered significant attention in the field of endocrinology and metabolic research. Structurally similar to native GLP-1, semaglutide is designed with modifications that enhance its half-life and resistance to degradation by dipeptidyl peptidase-4 (DPP-4). This peptide binds to and activates the GLP-1 receptor, initiating a cascade of physiological responses that affect glucose homeostasis, appetite regulation, and cardiovascular function. Requires reconstitution before use.